Alnylam Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all Alnylam Pharmaceuticals patents 222 in total
| Status | Patent |
|---|---|
Grant | Utility: Complement component iRNA compositions and methods of use thereof Filling date: 8 Sep 2025 Issue date: 5 Nov 2019 |
Application | Utility: ENDOSOMAL CLEAVABLE LINKERS Filling date: 8 Sep 2025 Issue date: 31 Oct 2019 |
Application | Utility: ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 17 Oct 2019 |
Application | Utility: SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 17 Oct 2019 |
Application | Utility: Compositions and Methods for Inhibiting Expression of Transthyretin Filling date: 8 Sep 2025 Issue date: 10 Oct 2019 |
Application | Utility: ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 3 Oct 2019 |
Application | Utility: ASSAYS AND METHODS FOR DETERMINING ACTIVITY OF A THERAPEUTIC AGENT IN A SUBJECT Filling date: 8 Sep 2025 Issue date: 26 Sep 2019 |
Application | Utility: TMPRSS6 iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 19 Sep 2019 |
Application | Utility: DOSAGES AND METHODS FOR DELIVERING LIPID FORMULATED NUCLEIC ACID MOLECULES Filling date: 8 Sep 2025 Issue date: 19 Sep 2019 |
Grant | Utility: Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof Filling date: 8 Sep 2025 Issue date: 10 Sep 2019 |
Application | Utility: COMPOSITIONS AND METHODS FOR THE MANUFACTURE OF LIPID NANOPARTICLES Filling date: 8 Sep 2025 Issue date: 5 Sep 2019 |
Grant | Utility: Compositions and methods for inhibiting expression of the ALAS1 gene Filling date: 8 Sep 2025 Issue date: 3 Sep 2019 |
Grant | Utility: Polynucleotide agents targeting complement component C5 and methods of use thereof Filling date: 8 Sep 2025 Issue date: 3 Sep 2019 |
Application | Utility: THERAPEUTIC COMPOSITIONS Filling date: 8 Sep 2025 Issue date: 29 Aug 2019 |
Application | Utility: GLYCOCONJUGATES OF RNA INTERFERENCE AGENTS Filling date: 8 Sep 2025 Issue date: 29 Aug 2019 |
Application | Utility: COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) Filling date: 8 Sep 2025 Issue date: 22 Aug 2019 |
Grant | Utility: Oligonucleotide end caps Filling date: 8 Sep 2025 Issue date: 20 Aug 2019 |
Application | Utility: MODIFIED DOUBLE-STRANDED RNA AGENTS Filling date: 8 Sep 2025 Issue date: 8 Aug 2019 |
Application | Utility: MODIFIED DOUBLE-STRANDED RNA AGENTS Filling date: 8 Sep 2025 Issue date: 8 Aug 2019 |
Grant | Utility: Ketohexokinase (KHK) iRNA compositions and methods of use thereof Filling date: 8 Sep 2025 Issue date: 6 Aug 2019 |
Grant | Utility: Biodegradable lipids for the delivery of active agents Filling date: 8 Sep 2025 Issue date: 6 Aug 2019 |
Application | Utility: METHODS AND COMPOSITIONS FOR TREATING INSECTS Filling date: 8 Sep 2025 Issue date: 1 Aug 2019 |
Showing 200 to 222 of 222 patents.